Bone 0 4 0 4 B-clinical_variable
Mineral 5 12 5 12 I-clinical_variable
Density 13 20 13 20 I-clinical_variable
( 21 22 21 22 I-clinical_variable
BMD 22 25 22 25 I-clinical_variable
) 25 26 25 26 I-clinical_variable
t 27 28 27 28 I-clinical_variable
score 29 34 29 34 I-clinical_variable
< 35 36 35 36 O
-3.0 37 41 37 41 O
at 42 44 42 44 O
the 45 48 45 48 O
total 49 54 49 54 O
hip 55 58 55 58 O
or 59 61 59 61 O
lumbar 62 68 62 68 O
spine 69 74 69 74 O

Cardiovascular 0 14 75 89 B-chronic_disease
disease 15 22 90 97 I-chronic_disease
; 22 23 97 98 O
subjective 24 34 99 109 O
or 35 37 110 112 O
objective 38 47 113 122 O
indicators 48 58 123 133 O
of 59 61 134 136 O
ischemic 62 70 137 145 B-chronic_disease
heart 71 76 146 151 I-chronic_disease
disease 77 84 152 159 I-chronic_disease
( 85 86 160 161 O
e.g. 86 90 161 165 O
, 90 91 165 166 O
angina 92 98 167 173 B-chronic_disease
, 98 99 173 174 O
ST 100 102 175 177 B-chronic_disease
segment 103 110 178 185 I-chronic_disease
depression 111 121 186 196 I-chronic_disease
) 121 122 196 197 O
or 123 125 198 200 O
serious 126 133 201 208 O
arrhythmias 134 145 209 220 B-chronic_disease
at 146 148 221 223 O
rest 149 153 224 228 O
or 154 156 229 231 O
during 157 163 232 238 O
the 164 167 239 242 O
graded 168 174 243 249 O
exercise 175 183 250 258 O
test 184 188 259 263 O
( 189 190 264 265 O
GXT 190 193 265 268 O
) 193 194 268 269 O
without 195 202 270 277 O
follow 203 209 278 284 O
- 209 210 284 285 O
up 210 212 285 287 O
evaluation 213 223 288 298 O
will 224 228 299 303 O
be 229 231 304 306 O
cause 232 237 307 312 O
for 238 241 313 316 O
exclusion 242 251 317 326 O
; 251 252 326 327 O
follow 253 259 328 334 O
- 259 260 334 335 O
up 260 262 335 337 O
evaluation 263 273 338 348 O
must 274 278 349 353 O
include 279 286 354 361 O
diagnostic 287 297 362 372 O
testing 298 305 373 380 O
( 306 307 381 382 O
e.g. 307 311 382 386 O
, 311 312 386 387 O
stress 313 319 388 394 O
echocardiogram 320 334 395 409 O
or 335 337 410 412 O
thallium 338 346 413 421 O
stress 347 353 422 428 O
test 354 358 429 433 O
) 358 359 433 434 O
with 360 364 435 439 O
interpretation 365 379 440 454 O
by 380 382 455 457 O
a 383 384 458 459 O
cardiologist 385 397 460 472 O

Currently 0 9 473 482 O
taking 10 16 483 489 O
a 17 18 490 491 O
bisphosphonate 19 33 492 506 B-treatment
medication 34 44 507 517 I-treatment

Diagnosis 0 9 518 527 O
or 10 12 528 530 O
history 13 20 531 538 O
of 21 23 539 541 O
asthma 24 30 542 548 B-chronic_disease

History 0 7 549 556 O
of 8 10 557 559 O
type 11 15 560 564 B-chronic_disease
1 16 17 565 566 I-chronic_disease
or 18 20 567 569 I-chronic_disease
type 21 25 570 574 I-chronic_disease
2 26 27 575 576 I-chronic_disease
diabetes 28 36 577 585 I-chronic_disease

Moderate 0 8 586 594 B-chronic_disease
or 9 11 595 597 I-chronic_disease
severe 12 18 598 604 I-chronic_disease
renal 19 24 605 610 I-chronic_disease
impairment 25 35 611 621 I-chronic_disease
defined 36 43 622 629 O
as 44 46 630 632 O
an 47 49 633 635 O
estimated 50 59 636 645 B-clinical_variable
glomerular 60 70 646 656 I-clinical_variable
filtration 71 81 657 667 I-clinical_variable
rate 82 86 668 672 I-clinical_variable
of 87 89 673 675 O
< 90 91 676 677 O
60 91 93 677 679 B-upper_bound
mL 94 96 680 682 I-upper_bound
/ 96 97 682 683 I-upper_bound
min/1.73m2 97 107 683 693 I-upper_bound
based 108 113 694 699 O
on 114 116 700 702 O
the 117 120 703 706 O
Modified 121 129 707 715 O
Diet 130 134 716 720 O
in 135 137 721 723 O
Renal 138 143 724 729 O
Disease 144 151 730 737 O
( 152 153 738 739 O
MDRD 153 157 739 743 O
) 157 158 743 744 O
equation 159 167 745 753 O

Serum 0 5 754 759 B-clinical_variable
calcium 6 13 760 767 I-clinical_variable
< 14 15 768 769 O
8.5 15 18 769 772 B-upper_bound
or 19 21 773 775 O
> 22 23 776 777 O
10.3 23 27 777 781 B-lower_bound
mg 28 30 782 784 I-lower_bound
/ 30 31 784 785 I-lower_bound
dL 31 33 785 787 I-lower_bound
Serum 34 39 788 793 B-clinical_variable
25(OH)D 40 47 794 801 I-clinical_variable
< 48 49 802 803 O
20 49 51 803 805 O
ng 52 54 806 808 O
/ 54 55 808 809 O
mL 55 57 809 811 O
; 57 58 811 812 O
volunteers 59 69 813 823 O
with 70 74 824 828 O
abnormal 75 83 829 837 B-clinical_variable
serum 84 89 838 843 I-clinical_variable
25(OH)D 90 97 844 851 I-clinical_variable
values 98 104 852 858 I-clinical_variable
may 105 108 859 862 O
be 109 111 863 865 O
re 112 114 866 868 O
- 114 115 868 869 O
considered 115 125 869 879 O
for 126 129 880 883 O
participation 130 143 884 897 O
in 144 146 898 900 O
the 147 150 901 904 O
study 151 156 905 910 O
if 157 159 911 913 O
serum 160 165 914 919 O
25(OH)D 166 173 920 927 O
is 174 176 928 930 O
> 177 178 931 932 O
20 178 180 932 934 O
ng 181 183 935 937 O
/ 183 184 937 938 O
mL 184 186 938 940 O
after 187 192 941 946 O
vitamin 193 200 947 954 B-treatment
D 201 202 955 956 I-treatment
supplementation 203 218 957 972 I-treatment

Thyroid 0 7 973 980 B-chronic_disease
dysfunction 8 19 981 992 I-chronic_disease
, 19 20 992 993 O
defined 21 28 994 1001 O
as 29 31 1002 1004 O
an 32 34 1005 1007 O
ultrasensitive 35 49 1008 1022 B-clinical_variable
TSH 50 53 1023 1026 I-clinical_variable
< 54 55 1027 1028 O
0.5 55 58 1028 1031 B-upper_bound
or 59 61 1032 1034 O
> 62 63 1035 1036 O
5.0 63 66 1036 1039 B-lower_bound
mU 67 69 1040 1042 I-lower_bound
/ 69 70 1042 1043 I-lower_bound
L 70 71 1043 1044 I-lower_bound
; 71 72 1044 1045 O
volunteers 73 83 1046 1056 O
with 84 88 1057 1061 O
abnormal 89 97 1062 1070 O
TSH 98 101 1071 1074 O
values 102 108 1075 1081 O
will 109 113 1082 1086 O
be 114 116 1087 1089 O
re 117 119 1090 1092 O
- 119 120 1092 1093 O
considered 120 130 1093 1103 O
for 131 134 1104 1107 O
participation 135 148 1108 1121 O
in 149 151 1122 1124 O
the 152 155 1125 1128 O
study 156 161 1129 1134 O
after 162 167 1135 1140 O
follow 168 174 1141 1147 O
- 174 175 1147 1148 O
up 175 177 1148 1150 O
evaluation 178 188 1151 1161 O
by 189 191 1162 1164 O
the 192 195 1165 1168 O
PCP 196 199 1169 1172 O
with 200 204 1173 1177 O
initiation 205 215 1178 1188 O
or 216 218 1189 1191 O
adjustment 219 229 1192 1202 O
of 230 232 1203 1205 O
thyroid 233 240 1206 1213 B-treatment
hormone 241 248 1214 1221 I-treatment
replacement 249 260 1222 1233 I-treatment

Uncontrolled 0 12 1234 1246 O
hypertension 13 25 1247 1259 B-chronic_disease
defined 26 33 1260 1267 O
as 34 36 1268 1270 O
resting 37 44 1271 1278 O
systolic 45 53 1279 1287 B-clinical_variable
BP 54 56 1288 1290 I-clinical_variable
> 57 58 1291 1292 O
150 58 61 1292 1295 B-lower_bound
mmHg 62 66 1296 1300 I-lower_bound
or 67 69 1301 1303 O
diastolic 70 79 1304 1313 B-clinical_variable
BP>90 80 85 1314 1319 I-clinical_variable
mmHg 86 90 1320 1324 I-lower_bound
; 90 91 1324 1325 O
participants 92 104 1326 1338 O
who 105 108 1339 1342 O
do 109 111 1343 1345 O
not 112 115 1346 1349 O
meet 116 120 1350 1354 O
these 121 126 1355 1360 O
criteria 127 135 1361 1369 O
at 136 138 1370 1372 O
first 139 144 1373 1378 O
screening 145 154 1379 1388 O
will 155 159 1389 1393 O
be 160 162 1394 1396 O
re 163 165 1397 1399 O
- 165 166 1399 1400 O
evaluated 166 175 1400 1409 O
, 175 176 1409 1410 O
including 177 186 1411 1420 O
after 187 192 1421 1426 O
follow 193 199 1427 1433 O
- 199 200 1433 1434 O
up 200 202 1434 1436 O
evaluation 203 213 1437 1447 O
by 214 216 1448 1450 O
the 217 220 1451 1454 O
PCP 221 224 1455 1458 O
with 225 229 1459 1463 O
initiation 230 240 1464 1474 O
or 241 243 1475 1477 O
adjustment 244 254 1478 1488 O
of 255 257 1489 1491 O
anti 258 262 1492 1496 B-treatment
- 262 263 1496 1497 I-treatment
hypertensive 263 275 1497 1509 I-treatment
medications 276 287 1510 1521 I-treatment

Use 0 3 1522 1525 O
of 4 6 1526 1528 O
medications 7 18 1529 1540 O
( 19 20 1541 1542 O
other 20 25 1542 1547 O
than 26 30 1548 1552 O
bisphosphonates 31 46 1553 1568 B-treatment
) 46 47 1568 1569 O
in 48 50 1570 1572 O
the 51 54 1573 1576 O
past 55 59 1577 1581 B-upper_bound
6 60 61 1582 1583 I-upper_bound
months 62 68 1584 1590 I-upper_bound
known 69 74 1591 1596 O
to 75 77 1597 1599 O
affect 78 84 1600 1606 O
bone 85 89 1607 1611 O
metabolism 90 100 1612 1622 O
( 101 102 1623 1624 O
e.g. 102 106 1624 1628 O
, 106 107 1628 1629 O
thiazide 108 116 1630 1638 B-treatment
diuretics 117 126 1639 1648 I-treatment
, 126 127 1648 1649 O
oral 128 132 1650 1654 B-treatment
glucocorticoids 133 148 1655 1670 I-treatment
) 148 149 1670 1671 O

aged 0 4 1672 1676 B-age
60 5 7 1677 1679 B-lower_bound
- 7 8 1679 1680 O
80 8 10 1680 1682 B-upper_bound
y 11 12 1683 1684 I-upper_bound

